Descriptor English: | Paramethasone | ||||
Descriptor Spanish: |
Parametasona
| ||||
Descriptor Portuguese: | Parametasona | ||||
Descriptor French: | Paraméthasone | ||||
Tree number(s): |
D04.210.500.745.432.769.692 D04.210.500.908.727 |
||||
RDF Unique Identifier: | https://id.nlm.nih.gov/mesh/D010248 | ||||
Scope note: | A glucocorticoid with the general properties of corticosteroids. It has been used by mouth in the treatment of all conditions in which corticosteroid therapy is indicated except adrenal-deficiency states for which its lack of sodium-retaining properties makes it less suitable than HYDROCORTISONE with supplementary FLUDROCORTISONE. (From Martindale, The Extra Pharmacopoeia, 30th ed, p737) |
||||
Allowable Qualifiers: |
AA analogs & derivatives AD administration & dosage AE adverse effects AG agonists AI antagonists & inhibitors AN analysis BL blood CF cerebrospinal fluid CH chemistry CL classification CS chemical synthesis EC economics HI history IM immunology IP isolation & purification ME metabolism PD pharmacology PK pharmacokinetics PO poisoning RE radiation effects SD supply & distribution ST standards TO toxicity TU therapeutic use UR urine |
||||
Pharm Action: |
Anti-Inflammatory Agents Glucocorticoids |
||||
Registry Number: | VFC6ZX3584 | ||||
CAS Type 1 Name: | Pregna-1,4-diene-3,20-dione, 6-fluoro-11,17,21-trihydroxy-16-methyl-, (6alpha,11beta,16alpha)- | ||||
Public MeSH Note: | 65 |
||||
History Note: | 65(63) |
||||
DeCS ID: | 22600 | ||||
Unique ID: | D010248 | ||||
Documents indexed in the Virtual Health Library (VHL): | Click here to access the VHL documents | ||||
Date Established: | 1965/01/01 | ||||
Date of Entry: | 1999/01/01 | ||||
Revision Date: | 2016/05/31 |
-
-
CHEMICALS AND DRUGS
Polycyclic Compounds [D04]Polycyclic Compounds -
CHEMICALS AND DRUGS
Polycyclic Compounds [D04]Polycyclic Compounds
|
Paramethasone
- Preferred
Concept UI |
M0015883 |
Scope note | A glucocorticoid with the general properties of corticosteroids. It has been used by mouth in the treatment of all conditions in which corticosteroid therapy is indicated except adrenal-deficiency states for which its lack of sodium-retaining properties makes it less suitable than HYDROCORTISONE with supplementary FLUDROCORTISONE. (From Martindale, The Extra Pharmacopoeia, 30th ed, p737) |
Preferred term | Paramethasone |
We want your feedback on the new DeCS / MeSH website
We invite you to complete a survey that will take no more than 3 minutes.
Go to survey